Multimorbidity Is Associated With Symptom Severity and Disease Progression in Patients with Paroxysmal Atrial Fibrillation—Data From the RACE V Study
Authors:
- Colinda van DeutekomCDColinda van Deutekom
- Martijn E. van de LandeMLMartijn E. van de Lande
- Rajiv RamaRRRajiv Rama
- Bao‐Oanh NguyenBNBao‐Oanh Nguyen
- Martin E. W. HemelsMHMartin E. W. Hemels
- Mirko de MelisMMMirko de Melis
- Ulrich SchottenUSUlrich Schotten
- Harry J. G. M. CrijnsHCHarry J. G. M. Crijns
- Isabelle C. van GelderIGIsabelle C. van Gelder
Open Access
- 4 March 2025
- journal article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (5) , e034514
Abstract
Background: Multimorbidity is common among patients with atrial fibrillation (AF) and is associated with worse outcomes. We aimed to investigate the association between multimorbidity, AF progression and AF symptom severity in patients with paroxysmal AF. Methods and Results: The RACE V (Reappraisal of AF: Interaction Between Hypercoagulability, Electrical Remodeling, and Vascular Destabilization in the Progression of AF) study included patients with paroxysmal AF and continuous rhythm monitoring. Multimorbidity was defined as ≥2 comorbidities (heart failure, hypertension, diabetes, coronary heart disease, kidney dysfunction, moderate or severe mitral valve regurgitation, or obesity). AF symptom severity was assessed via the University of Toronto AF Severity Scale questionnaire. The associations between multimorbidity, AF progression, and AF symptom severity were determined using logistic regression analyses. Median age was 65 (58–71) years and 179 of 417 patients (43%) were women, with a median of 1 (1–2) comorbidities. Median follow‐up was 2.2 (1.6–2.8) years. Multimorbidity was associated with AF progression (odds ratio [OR], 2.02 [95% CI, 1.10–3.72], P =0.024) and increased AF symptom severity (OR, 2.67 [95% CI, 1.79–3.99], P P =0.008), as well as AF symptom severity (OR, 1.64 [95% CI, 1.35–1.99], P <0.001). These results remained significant after adjusting for age. Conclusions: In patients with paroxysmal AF, multimorbidity was associated with AF progression and AF symptom severity. The risk of AF progression and AF symptom severity increased with every additional comorbidity. Registration: URL: clinicaltrials.gov . Unique Identifier: NCT02726698.Keywords
This publication has 25 references indexed in Scilit:
- Mobile app-based symptom-rhythm correlation assessment in patients with persistent atrial fibrillationInternational Journal of Cardiology, 2022
- Atrial Fibrillation and ObesityJACC: Clinical Electrophysiology, 2021
- Atrial fibrillation pattern and factors affecting the progression to permanent atrial fibrillationInternal and Emergency Medicine, 2020
- Symptom Burden Is Associated with Psychological Wellbeing and Mortality in Older AdultsThe Journal of nutrition, health and aging, 2020
- Association of Multimorbidity with Cardiovascular Endpoints and Treatment Effectiveness in Patients 75 Years and Older with Atrial FibrillationThe American Journal of Medicine, 2020
- Atrial Fibrillation and Diabetes MellitusJACC, 2019
- Progression of paroxysmal to persistent atrial fibrillation: 10-year follow-up in the Canadian Registry of Atrial FibrillationHeart Rhythm, 2017
- Progression From Paroxysmal to Persistent Atrial FibrillationJACC, 2010
- Atrial fibrillation progression and management: A 5-year prospective follow-up studyHeart Rhythm, 2008
- Quality of life improves with treatment in the Canadian Trial of Atrial FibrillationAmerican Heart Journal, 2002